Chemotherapy of brain tumors

Seminars in Surgical Oncology

Volumn 14, Issue 1, 1998, Pages 88-95

  Prados, Michael D ^a   Russo, Carolyn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult; Antineoplastic agents; Brain neoplasms; Child; Clinical trials; Cognitive disorders; Combined modality therapy; Glioma; Infant; Radiotherapy; Survival rate

Indexed keywords

CARMUSTINE; LOMUSTINE; METHYLPREDNISOLONE; PROCARBAZINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; GLIOBLASTOMA; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030817283     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199801/02)14:1<88::AID-SSU11>3.0.CO;2-5     Document Type: Article

References (44)

1. Walker MD, Alexander E Jr, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma. J Neurosurg 1978; 49:333-343.
2. Green SB, Byer DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methlyprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67:121-132.
3. Levin VA, Silver P, Hannigan J, et al: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiât Oncol Biol Phys 1990; 18:321-324.
4. Deutsch M, Green SB, Strike TA, et al: Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU followed by misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiât Oncol Biol Phys 1989; 16:1389-1397.
5. Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989; 71:1-9.
6. Shapiro WR, Green SB, Burger PC, et al: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992; 76:772-781.
7. Nomura K, WatanabeT, Nakamura O, et al: Intensive chemotherapy with autologous bone marrow rescue in the treatment of recurrent malignant glioma. Neurosurg Rev 1984; 7:13-22.
8. Phillips GL, \Volff SN, Fay JW, et al: Intensive 1, 3-bis(2chloroethyl)-l-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 1986; 4:639-645.
9. Gioannone L, Wolff SN: Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 1987; 71:759-761.
10. CurranWJ Jr, Scott CB.HortonJ, et al: Recursive partitioning analysis in three Radiation Oncology Therapy Group malignant glioma trials [comment in: J Natl Cancer Inst 1993; 85:690-691]. J Natl Cancer Inst 1993; 85:704-710.
11. Warnick RE, Prados MD, Mack EE, et al: A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol 1994; 9:860-864.
12. Yung WKA, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 1991; 9:860-864.
13. Couldwell WT, Weiss MH, DeGiorgio CM, et al: Clinical and radiographie response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 1993; 32:485190.
14. Vertosik FT Jr, Selker RG, Pollack IF, Arena V: The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of failed patients. Neurosurgery 1992; 30:897-902.
15. Rodriquez LA, Prados M, Silver P, Levin VA: Réévaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer 1989; 64:2420-2423.
16. O'Reilly SM, Newlands ES, Classer MG, et al: Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer 1993; 29A:940-942.
17. Levin VA, Yung A, Prados M, et al: Phase II study of temodal at first relapse in anaplastic astrocytoma patients [abstract]. ProceedingsofASCO; 1997:I6:384a.
18. LevinVA,PradosMD,Yung\VK,etal:Treatmentofrecurrentgliomas with eflomithine. J Natl Cancer Inst 1992; 84:1432-1437.
19. Wiestler O, Kleihues P, Peg AE: 06-alkylguanine-DNA alkyl-transferase activity in human brain and brain tumors. Carcinogen-! esis 1984; 5:121-124.
20. Freedman HS, Dolan ME, Moschel RC, et al: Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 1992; 84:1926-1931.
21. Cohen ME, Duffner PK: "Brain tumors in children: principles of diagnosis and treatment. " 2nd ed. New York: Raven Press, 1994.
22. Friedman HS, Oakes WJ: The chemotherapy of posterior fossa tumors in childhood. J Neurooncol 1987; 5:217-229.
23. Mosijczuk AD, Nigro MA, Thomas PR, et al: Preradiation chemotherapy in advanced medulloblastoma. Cancer 1993; 72:2755-2762.
24. Tait DM, Thornton-Jones H, Bloom HJ, et al: Adjuvant chemo-therapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP 1). Eur J Cancer 1990; 26:464-469.
25. Evans AE, Jenkin DT, Sposto R, et al: The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990; 72:572-582.
26. Packer RJ, Sutton LN, Goldwein JW, et al: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991; 74:433-440.
27. Packer RJ, Sutton LN, EIterman R, et al: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81:690-698.
28. Heideman RL, Kovnar EH, Kellie SJ, et al: Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pédiatrie CNS tumors [comment in: J Clin Oncol 1996; 14:1741]. ' J Clin Oncol 1995; 13:2247-2254.
29. Duffner PK, Cohen ME, Myers MH, Heise H\V: Survival of children with brain tumors: SEER Program, 1973-1980. Neurology 1986; 36:597-601.
30. Packer RJ, Sutton LM, Atkins TE, et al: A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 1989; 70:707-713.
31. Hoppe-Hirsch E, Renier D, Lellouch-Tubiana A, et al: Medulloblastoma in childhood: progressive intellectual deterioration. Childs NervSyst 1990; 6:60-65.
32. Duffner PK, Horowitz ME, Krischer JP, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors [comment in: N Engl J Med 1993; 328:1780-1781; N Engl J Med 1993; 329:1963-1964]. N Engl J Med 1993; 328:1725-1731.
33. Geyer JR, Zeltzer PM, Boyett JM, et al: Survival of infants with primitive neuroectodermal tumors or malignant ependymoma of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J Clin Oncol 1994; 12:1607-1615.
34. Packer RJ, Sutton LM, Bilaniuk LT, et al: Treatment of chiasmatic/ hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neural 1988; 23:79-85.
35. Janss AJ, Grundy R, Cnaan A, et al: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995; 75:1051-1059.
36. Van Eys J, Cangir A, Coady D, Smith B: MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1984; 3:237-244.
37. Lefkowitz IB, Packer RJ, Sutton LN, et al: Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer 1988; 61:896-902.
38. Prados MD, Edwards MS, Rabbit! J, et al: Treatment of pédiatrie low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-Oncology 1997; 32:235-241.
39. Moghrabi A, Friedman HS, Burger PC, et al: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 1993; 79:223-227.
40. Packer RJ, Lange B, Ater J, et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas in childhood. J Clin Oncol 1993; 11:850-856.
41. Edwards MS, Levin VA, Wilson CB: Chemotherapy of pédiatrie posterior fossa tumors. Childs Brain 1980; 7:252-260.
42. Jenkin RD, Boesel C, Ertel I, et al: Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. J Neurosurg 1987; 66:227-233.
43. Kretschmar CS, Tarbell NJ, Bames PD, et al: Pré-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brainstem tumors. A phase II study of the Pédiatrie Oncology Group, Protocol 8833. Cancer 1993; 72:1404-1413.
44. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL: Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: aChildren's Cancer Group Study. Med Ped Oncol 1996; 27:8-14.